Avecia Explained

Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production.[1] Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH. In 2016 Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals.[2]

External links

Notes and References

  1. News: Nitto Denko lays out $226M to boost oligonucleotide production in a bustling RNA market. Fierce Pharma. Kansteiner. Fraiser. March 31, 2021. June 3, 2024.
  2. News: Nitto Denko Avecia Inc acquires businesses of Irvine Pharmaceutical Services, Avrio Biopharmaceuticals. Reuters. October 11, 2016. June 3, 2024.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Avecia".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.